Your browser doesn't support javascript.
loading
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals.
Moldt, Brian; Günthard, Huldrych F; Workowski, Kimberly A; Little, Susan J; Eron, Joseph J; Overton, Edgar T; Lehmann, Clara; Rokx, Casper; Kozal, Michael J; Gandhi, Rajesh T; Braun, Dominique L; Parvangada, Aiyappa; Li, Jiani; Martin, Ross; Selzer, Lisa; Cox, Stephanie; Margot, Nicolas; Liu, Hui; Slamowitz, Debbie; Makadzange, Tariro; Collins, Sean E; Geleziunas, Romas; Callebaut, Christian.
Afiliação
  • Moldt B; Gilead Sciences, Inc., California, USA.
  • Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
  • Workowski KA; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Little SJ; Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia.
  • Eron JJ; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California.
  • Overton ET; Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, North Carolina.
  • Lehmann C; Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine, Alabama, USA.
  • Rokx C; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Kozal MJ; German Center for Infection Research, Partner Site Bonn-Cologne.
  • Gandhi RT; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Braun DL; Department of Internal Medicine, and.
  • Parvangada A; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Li J; Yale School of Medicine, New Haven, Connecticut.
  • Martin R; Massachusetts General Hospital and Harvard Medical School, Cambridge, Massachusett, USA.
  • Selzer L; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich.
  • Cox S; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Margot N; Gilead Sciences, Inc., California, USA.
  • Liu H; Gilead Sciences, Inc., California, USA.
  • Slamowitz D; Gilead Sciences, Inc., California, USA.
  • Makadzange T; Gilead Sciences, Inc., California, USA.
  • Collins SE; Gilead Sciences, Inc., California, USA.
  • Geleziunas R; Gilead Sciences, Inc., California, USA.
  • Callebaut C; Gilead Sciences, Inc., California, USA.
AIDS ; 36(2): 205-214, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34586088
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article